Cytokines and production of surfactant components (Q41165211)

27 September 2017

1 reference

title

Cytokines and production of surfactant components (English)

1 reference

27 September 2017

Bry K

1

1 reference

27 September 2017

Lappalainen U

series ordinal

2

1 reference

27 September 2017

Hallman M

series ordinal

3

1 reference

27 September 2017

publication date

1 June 1996

1 reference

27 September 2017

published in

Seminars in Perinatology

1 reference

27 September 2017

volume

20

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

194-205

1 reference

Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Physicochemical properties of dipalmitoyl phosphatidylcholine after interaction with an apolipoprotein of pulmonary surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Surfactant proteins A and D.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Constitutive expression of TNF-alpha and -beta genes in mouse embryo: roles of cytokines as regulator and effector on development

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Human eosinophils express transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Expression of Transforming Growth Factor-α in Mid-gestation Human Fetal Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Transforming growth factor-alpha gene expression in late-gestation fetal rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Effect of Epidermal Growth Factor on Lung Maturation in Fetal Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Epidermal and nerve growth factors in mammalian development

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

The physiology of transforming growth factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Influence of epidermal growth factor on fetal rat lung development in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Epidermal Growth Factor Transcription, Translation, and Signal Transduction by Rat Type II Pneumocytes in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Synergistic hormonal effects on lung maturation in fetal sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Sex-specific differences in rabbit fetal lung maturation in response to epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Developmental pattern of urinary epidermal growth factor in the premature infant and the influence of gender.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Effects of anti-mouse EGF antiserum on prenatal lung development in fetal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Strain-dependent epithelial defects in mice lacking the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

The role of TGF-beta s in mammalian development and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Inflammatory and immunomodulatory roles of TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Proteoglycans as modulators of growth factor activities

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

High levels of transforming growth factor-beta are present in the epithelial lining fluid of the normal human lower respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Type beta transforming growth factor: a bifunctional regulator of cellular growth

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGF beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Fetal rat lung fibroblasts produce a TGF beta homolog that blocks alveolar type II cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Transforming growth factor-beta inhibits surfactant protein A expression in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

A tumor necrosis factor binding protein is present in human biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) in tracheal aspirates of newborns with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Increased Plasma Concentrations of Interleukin-1 Receptor Antagonist in Neonatal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Serum tumour necrosis factor in newborns at risk for infections

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor in preterm and term labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Tumor Necrosis Factor-α Inhibits Surfactant Protein C Gene Transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interferon-gamma and synthesis of surfactant components by cultured human fetal lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Role of interleukin-1 in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980048-6

7 January 2021

10.1016/S0146-0005(96)80048-6

Identifiers

DOI

1 reference

27 September 2017

1 reference